However, blockade of PD-1 enhances T-cell function and the subsequent production of inflammatory cytokines, most notably IFN-γ, which enhances PD-L1 and PD-L2 expression on tumor cells, thereby inducing negative feedback as well as other immunosuppressive pathways [227,229,236]. Here, PDCD1LG2 is linked to neoplasm.